Status:
TERMINATED
Patient Compliance With Long-Acting Reversible Contraception Administration
Lead Sponsor:
Tulane University School of Medicine
Conditions:
Contraception
Eligibility:
FEMALE
15+ years
Phase:
NA
Brief Summary
This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum hospital st...
Detailed Description
Randomized control trial with control group receiving LARC at 6 weeks postpartum and the study group receiving LARC in the immediate or early postpartum period. Outcomes will be measured by those who ...
Eligibility Criteria
Inclusion
- Pregnant, desires LARC postpartum
Exclusion
- Medical contraindication to desired LARC, vaginal delivery complicated by fourth degree perineal laceration, history of pelvic inflammatory disease, uterine infection
Key Trial Info
Start Date :
October 22 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2016
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03305081
Start Date
October 22 2014
End Date
May 31 2016
Last Update
January 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tulane Department of Obstetrics and Gynecology
New Orleans, Louisiana, United States, 70018